Management of raised blood pressure in New Zealand: a discussion document. - Wikidata - wikimedia - TriplyDB

Management of raised blood pressure in New Zealand: a discussion document.

Management of raised blood pressure in New Zealand: a discussion document.

http://www.wikidata.org/entity/Q35214317

about

The current status of primary prevention in coronary heart disease A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension Screening for diabetes: what are we really doing?Efficacy of treating hypertension in women.What is the optimal age for starting lipid lowering treatment? A mathematical model.The costs of not treating hypertension.Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study.An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.When should hypertension be treated? The different perspectives of Canadian family physicians and patients.Pharmacotherapy for hypertension in women of different races.A general practice-based study examining the absolute risk of cardiovascular disease in treated hypertensive patients Same information, different decisions: the influence of evidence on the management of hypertension in the elderly Auditing the management of hypertension in British general practice: a critical literature review Addressing barriers to change: an RCT of practice-based education to improve the management of hypertension in the elderly.Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.The primary prevention of coronary heart disease with statins: practice headache or public health?Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation.Meeting the National Service Framework for coronary heart disease: which patients have untreated high blood pressure?Management of hypertension in the elderly: attitudes of general practitioners and hospital physicians.Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men A coronary heart disease risk score based on patient-reported information Efficacy and tolerability of a β-1 selective β blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study.The impact of implementing national hypertension guidelines on prevalence and workload in primary care: a population-based survey of older people.Cardiovascular risk and risk reduction: a review of recent literature A simple computer program for guiding management of cardiovascular risk factors and prescribing.What constitutes controlled hypertension? Patient based comparison of hypertension guidelines.Blood pressure and mortality in healthy old people: the r shaped curve Ambulatory blood pressure monitoring: a guide for general practitioners.Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self-assessing coronary risk.Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease.Individualization of therapy for hypertension in the 1990's: the role of calcium antagonists.Models to predict cardiovascular risk: comparison of CART, multilayer perceptron and logistic regression.Prediction of cardiovascular risk. Program is not suitable for diabetic patients.Who benefits from medical interventions?Guidelines on preventing cardiovascular disease in clinical practice.

P2860

Q24793532-7E8524DB-C670-44C3-8C95-418A3FE7B720 Q28196568-ADC33ADA-A641-40B8-9997-B202D40E6741 Q28219296-1FDFCC71-9FAF-422B-96EE-E32B15D8488E Q30234498-B137EF1F-E5D6-423D-8D50-22B64371FAF7 Q30499043-A0FBA8AB-4C8A-4380-96AB-152FC746C38C Q30499045-DA6C98E5-CBC4-4CC9-97CB-B07F0DEEB9BF Q33792943-2017565B-5662-4F51-8BDE-0B2C448D04DF Q33815830-F585D600-37B3-404F-B034-4ED89EC46AD7 Q33816882-EB2DBF29-07E6-4FE9-AC3B-B3336DC9D5FA Q33851737-738E8E24-D15F-4D9C-9419-A1FB466272CF Q33895122-531E6F29-C106-477B-A0A9-B142C840C3AF Q33925329-3C92EB57-7FB9-4CF3-8823-6A19185FC096 Q33954529-0749868B-6866-4185-8AFA-6C8146DD60FA Q33978534-2ABD0709-1648-4BA0-98AA-58A8927D88B9 Q34055326-F9198B54-366D-4B0B-8D40-FE33A51AA577 Q34055328-606623A1-CEA7-4812-8799-A31C2D9A114A Q34215364-1AB29D8F-85E7-489F-A127-50B9D417258F Q34217158-9E7C1CBE-FF0D-450C-A5C1-60074D521DA0 Q34219006-A3BA6827-B76F-4818-990A-97AE5E10171B Q34219017-BE4CC932-8D0E-4015-A8D4-53F55034D0A3 Q34219027-E3A0816E-345F-4364-BC81-26CAD1724BED Q34220479-DAB00EEC-4219-4B38-B54B-669A1CD745E1 Q34347209-1F3B1CBB-B870-4D9D-9AF1-52039774AB7B Q35370250-AF4024EE-DC17-4E2E-9364-3BE234140383 Q35910702-8BDE5285-7628-41FE-A15D-858FE939781B Q35981791-612BD1A7-493F-43F6-A427-69287B2E7967 Q36141616-60EFCE41-9D0C-44BF-9EF2-8980D2250433 Q36219177-20E18B33-1AEB-472E-954E-C6A432B278FF Q36266660-A165D247-B5F3-4F3B-A4C9-C756435A3A45 Q36599250-F1103C84-45AE-4E7B-B980-D4FB734E9139 Q36601091-E246D512-AAE1-4B86-B94D-6D15CDA83DFC Q36601808-56C93C27-45AF-43A4-AC11-365148C662BA Q37316430-95B51ADF-E21E-4527-9441-CDBE0E9A0358 Q37331446-98F6CD32-B485-46F6-8852-67AD9433A23B Q40130915-85903782-7FD9-48E9-8B5A-94479D71AA8B Q40594646-B05596BB-8D20-44CC-9FE7-7BC19C34E553 Q41969575-959B801F-0655-4443-B605-02F574DF5EAA Q42259214-4B303F9A-49B9-4272-BB4A-EEE5C5443624 Q42559606-A58EBE1F-D3F5-49DF-9163-B13ABECBA0D1 Q42766542-69868875-E3DB-4726-8E57-8235C3936B2D

P2860

Management of raised blood pressure in New Zealand: a discussion document.

http://www.wikidata.org/entity/Q35214317

description

1993 nî lūn-bûn

@nan

1993 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Management of raised blood pressure in New Zealand: a discussion document.

@ast

Management of raised blood pressure in New Zealand: a discussion document.

@en

type

label

Management of raised blood pressure in New Zealand: a discussion document.

@ast

Management of raised blood pressure in New Zealand: a discussion document.

@en

prefLabel

Management of raised blood pressure in New Zealand: a discussion document.

@ast

Management of raised blood pressure in New Zealand: a discussion document.

@en

P1433

Q35214317-6E5FDBC7-84E0-41D9-A70C-C6C0CB975F8D

P1476

Q35214317-CEA90308-0D65-4E89-904A-6CCE57046BB1

P2093

Q35214317-0E84D44A-852D-40FD-82E5-DE8331964EF3

Q35214317-4E25DF64-BAB7-4A75-AB65-9563F9BEBB90

Q35214317-5E510D20-CAB7-4BFC-97ED-C0C166C94E01

Q35214317-64D4A437-851E-4BBD-A8C5-2CCF787A58A6

Q35214317-7B527CF1-F469-4857-B2AB-6B7B07EDA460

Q35214317-A0EFC1C5-67CB-44C8-8A84-F0F1A4FC7808

Q35214317-C656DF18-9679-4AFB-B0A8-58F651837C77

P2860

Q35214317-115E639B-8FB6-4E45-8754-CA396F7D6AFA

Q35214317-4CDDEA16-6440-49A0-91E9-112C517882EC

Q35214317-59E7FCBB-A28F-480F-A4F0-4278DCEE29A4

Q35214317-88F2E55A-E2ED-480A-A3CE-B4F86AA990E6

Q35214317-8D1423E7-6322-4ADF-89CB-BEE2171D3727

Q35214317-AA7A794E-4158-496E-B9AF-CA6A1B123424

P304

Q35214317-B8B31827-C6E7-4E4E-9FA2-45192374A4AA

P31

Q35214317-A9C289B9-404D-4162-99C8-2AB1D77B3EA9

P356

Q35214317-B7603A02-BF5A-4ED5-A7B9-29F0AF77A1F8

P407

Q35214317-C499EF09-31EA-497F-A285-FCCBBB4240B9

P433

Q35214317-D42DC492-904F-4F6E-B8C1-88176C46E39D

P478

Q35214317-11F1781D-B940-4ED2-8E2A-365F2FED0F01

P577

Q35214317-F5B492E4-FBE1-43EB-8364-16C1702436CA

P5875

Q35214317-ACD44FEB-4C92-4DD0-ADD6-0D52EDE35A60

P698

Q35214317-5DD64A04-211C-4F85-8EC2-5D702DEF4F9B

P921

Q35214317-50064ABB-6774-4812-9715-E0FFA35D9437

P932

Q35214317-173F6568-C68E-4D90-B712-E1BF1A83AD69

P356

BMJ.307.6896.107

P1433

P1476

Management of raised blood pressure in New Zealand: a discussion document.

@en

P2093

Barham P

http://www.w3.org/2001/XMLSchema#string

Bills J

http://www.w3.org/2001/XMLSchema#string

Birch T

http://www.w3.org/2001/XMLSchema#string

Jackson R

http://www.w3.org/2001/XMLSchema#string

MacMahon S

http://www.w3.org/2001/XMLSchema#string

Maling T

http://www.w3.org/2001/XMLSchema#string

McLennan L

http://www.w3.org/2001/XMLSchema#string

P2860

Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects

Blood pressure, stroke, and coronary heart disease

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

The evolution of antihypertensive therapy.

An updated coronary risk profile. A statement for health professionals.

P304

107-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.307.6896.107

http://www.w3.org/2001/XMLSchema#string

P407

P433

6896

http://www.w3.org/2001/XMLSchema#string

P478

307

http://www.w3.org/2001/XMLSchema#string

P577

1993-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14855007

http://www.w3.org/2001/XMLSchema#string

P698

8343706

http://www.w3.org/2001/XMLSchema#string

P921

P932

1693500

http://www.w3.org/2001/XMLSchema#string